4DMT

Anthony Baldor, Vice President, Corporate Strategy & Business Development

Oct. 12 | 11:30am | AVROBIO Ballroom

Emeryville, CA

(NASDAQ: FDMT)

In-person Presentation

4DMT is a gene therapy company with a transformative discovery platform – Therapeutic Vector Evolution – that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.

www.4dmt.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions